drs. W.J. Plattel

Research

Publications
  1. Mid-treatment TARC and mid-treatment FGD-PET predict for progression free survival in classical hodgkin lymphom

    Plattel, W. J., Berg, van den, A., Visser, L., Glaudemans, A., Diepstra, A. & van Imhoff, G., 20-Oct-2016, In : Haematologica. 101, p. 31-31 1 p., T014.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC

    Plattel, W. J., Alsada, Z. N. D., van Imhoff, G. W., Diepstra, A., van den Berg, A. & Visser, L., Dec-2016, In : British Journal of Haematology. 175, 5, p. 868-875 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Insulin-like growth factor 1 receptor is a prognostic factor in classical Hodgkin lymphoma

    Liang, Z., Diepstra, A., Xu, C., van Imhoff, G., Plattel, W., Van Den Berg, A. & Visser, L., 28-Jan-2014, In : PLoS ONE. 9, 1, 9 p., e87474.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma

    Xu, C., Plattel, W., van den Berg, A., Ruether, N., Huang, X., Wang, M., de Jong, D., Vos, H., van Imhoff, G., Viardot, A., Moeller, P., Poppema, S., Diepstra, A. & Visser, L., Apr-2012, In : Haematologica. 97, 4, p. 572-578 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (7) »

View graph of relations

ID: 273122